跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MOVAPO PEN apomorphine hydrochloride hemihydrate 30 mg/3 mL Solution for Injection, Cartridge - TGA Drug Approval Details
Approvals
/
TGA
/
MOVAPO PEN apomorphine hydrochloride hemihydrate 30 mg/3 mL Solution for Injection, Cartridge
Approved
STANDARD
MOVAPO PEN apomorphine hydrochloride hemihydrate 30 mg/3 mL Solution for Injection, Cartridge
Stada Pharmaceuticals Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
548dd9fa82492249
Company
Stada Pharmaceuticals Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
548dd9fa82492249
Product Name
MOVAPO PEN apomorphine hydrochloride hemihydrate 30 mg/3 mL Solution for Injection, Cartridge
Artg Id
275694
Artg Name
MOVAPO PEN apomorphine hydrochloride hemihydrate 30 mg/3 mL Solution for Injection, Cartridge
Sponsor
Stada Pharmaceuticals Australia Pty Ltd
Company Detail Path
/organization/stada-pharmaceuticals-australia-pty-limited
Artg Date
2017-11-03
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2018-CMI-01746-1
Product Information
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2017-PI-02618-1
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
548dd9fa82492249
Type
Standard
Back to TGA Approvals